TABLE 3.
Determination | Results for
patients with chromosome 22q11.2 deletion
|
||||
---|---|---|---|---|---|
Newborns
(n = 10)
|
1-yr-olds (n =
10)
|
P valuea | |||
Mean | 5–95% range | Mean | 5–95% range | ||
Absolute lymphocyte count (cells/mm3) | 2,159 | 1,548–2,771 | 4,953 | 2,962–6,945 | 0.017 |
CD3 | |||||
Cells/mm3 | 808 | 530–1,086 | 1,862 | 1,119–2,605 | 0.019 |
% | 33.2 | 16–50 | 40.7 | 32–50 | 0.343 |
CD4 | |||||
Cells/mm3 | 590 | 380–800 | 1,271 | 808–1,734 | 0.021 |
% | 29.1 | 20–39 | 27.3 | 21–33 | 0.625 |
CD8 | |||||
Cells/mm3 | 218 | 131–305 | 489 | 229–748 | 0.058 |
% | 11.1 | 6–16 | 13.2 | 6–21 | 0.363 |
TCRγδ | |||||
Cells/mm3 | 92 | 10–174 | 297 | 122–717 | 0.221 |
% | 1.6 | 0.4–3 | 2.8 | 1–4 | 0.046 |
CD5/19 | |||||
Cells/mm3 | 37 | 9–65 | 174 | 69–279 | 0.026 |
% | 2.2 | 0.3–5 | 5.9 | 2–10 | 0.062 |
CD19 | |||||
Cells/mm3 | 369 | 152–586 | 2,166 | 1,098–3,235 | 0.007 |
% | 19.5 | 9–29 | 42.8 | 37–49 | <0.001 |
CD16/56 | |||||
Cells/mm3 | 591 | 125–1,058 | 845 | 140–1,550 | 0.281 |
% | 25.1 | 8–42 | 14.4 | 8–20 | 0.112 |
PHA | |||||
cpm (n = 13) | 59,035 | 25,345–92,725 | 32,494 | 60,260–104,730 | 0.053 |
SI (n = 13) | 123 | 39–206 | 357 | 262–451 | 0.009 |
P values < 0.05 are boldfaced.